Skin has some ability to remodel itself after weight loss, especially if you are younger, have good genetics and support your body with healthy daily habits
Because these effects overlap, patients often notice improvements across the board skin, healing, and hair rather than in just one area
Experimental murine models induced with muscle contusion and muscular macrophage depletion were used as study subjects
By activating these receptors, tirzepatide: Enhances insulin secretion in a glucose-dependent manner (reducing hypoglycaemia risk) Suppresses glucagon release, lowering hepatic glucose production Slows gastric emptying, promoting satiety Acts on central appetite centres in the hypothalamus to reduce food intake In clinical trials (SURMOUNT programme), tirzepatide produced significant weight loss (typically 1520% of body weight at the highest doses in carefully selected trial populations) alongside improvements in glycaemic control
A good part of the human trial evidence is younger and less refined than what we see in animal models, although the trends are similar
